Parkinson’s disease develops when neurons that produce dopamine, a chemical messenger essential for movement, gradually die off in a specific region of the brain called the substantia nigra. For most people, no single cause explains why this happens. Instead, the disease typically results from a combination of genetic susceptibility, environmental exposures, and aging, with the vast majority of cases (90 to 95%) occurring without a clear inherited cause.
What Happens Inside the Brain
The core problem in Parkinson’s is the buildup of a misfolded protein called alpha-synuclein. Everyone’s brain cells produce this protein normally, but in Parkinson’s, it clumps together into toxic clusters called Lewy bodies. These clumps interfere with essential cell functions: they block the internal transport system cells use to move materials around, impair the cell’s ability to recycle damaged components, and disrupt the mitochondria, the tiny structures that generate energy for the cell.
Dopamine-producing neurons are especially vulnerable because the chemical byproducts of dopamine itself can modify alpha-synuclein in ways that make it more likely to form toxic clusters. As these neurons die, the brain loses its ability to coordinate smooth, voluntary movement. By the time someone develops the classic tremor or stiffness, roughly 60 to 80% of their dopamine-producing neurons are already gone.
Failing mitochondria play a central role in this process. When these cellular power plants malfunction, they produce less energy and generate more harmful molecules called free radicals, which damage the cell from the inside. Several of the genes linked to Parkinson’s directly affect how mitochondria function, repair themselves, or get replaced when they’re worn out.
Genetics: A Factor, Rarely the Whole Story
Only 5 to 10% of Parkinson’s cases are directly inherited through gene mutations. Researchers have identified at least 20 genes associated with familial Parkinson’s, with mutations in the LRRK2 gene being the most common. LRRK2 mutations account for 5 to 13% of inherited cases and even show up in 1 to 5% of cases with no family history at all. Mutations in the SNCA gene, which provides the blueprint for alpha-synuclein itself, tend to cause an earlier-onset form of the disease.
For the remaining 90 to 95% of cases, genetics still matters, just not in a straightforward way. Dozens of common gene variants each nudge risk up by a small amount. Having a first-degree relative with Parkinson’s increases your risk, but most people with that family history never develop the disease. Think of genetic susceptibility as a loaded deck rather than a guaranteed hand.
Environmental Exposures That Raise Risk
Certain chemicals damage dopamine-producing neurons in exactly the ways that mimic Parkinson’s. The pesticides rotenone and paraquat are the best studied: people who used either were 2.5 times more likely to develop Parkinson’s than those who didn’t. Rotenone directly poisons the energy-producing machinery inside cells, while paraquat generates a flood of free radicals. Both reproduce the hallmarks of Parkinson’s in animal studies.
Industrial solvents pose a similar threat. Trichloroethylene (TCE), widely used as a metal degreaser and dry-cleaning agent, has been linked to a 500% increased risk of Parkinson’s in a study of twin pairs where only one twin was exposed. Case reports describe workers developing Parkinson’s after 25 to 33 years of handling TCE on the job. One striking finding: the gap between TCE exposure and a Parkinson’s diagnosis can be 10 to 40 years, meaning the damage may be invisible for decades. TCE is not a rare substance. It has contaminated groundwater at military bases, industrial sites, and residential areas across the country.
The Disease May Start in the Gut
One of the more surprising findings in recent Parkinson’s research is that the disease may not always begin in the brain. Misfolded alpha-synuclein has been found in the nerves of the digestive tract in people with early, untreated Parkinson’s. A prominent theory proposes that environmental triggers in the gut, whether toxins, infections, or changes in gut bacteria, could initiate the protein misfolding there. The toxic clumps then travel up the vagus nerve, a long nerve highway connecting the gut to the brain, gradually spreading into the brain over years.
Supporting this idea, two large registry-based studies found that people who had their vagus nerve surgically cut (a procedure once used to treat ulcers) had a lower risk of developing Parkinson’s later. Gastrointestinal problems like constipation are also among the earliest symptoms of the disease, often appearing years or even decades before any tremor.
Age, Sex, and Head Injury
Age is the single strongest risk factor. The incidence rate climbs dramatically with each decade of life: from about 0.5 per 100,000 people per year in the 30-to-39 age group to 119 per 100,000 in those over 80. That’s roughly a 240-fold increase. Aging brings cumulative oxidative damage, declining mitochondrial function, and a reduced ability to clear misfolded proteins, all of which converge to make neurons more vulnerable.
Men develop Parkinson’s nearly twice as often as women, with an overall male-to-female ratio of about 1.9 to 1. The gap widens with age, reaching 2.7 to 1 in those over 80. Estrogen is thought to offer some neuroprotective benefit, though the exact mechanism remains unclear.
Traumatic brain injury also increases risk. A large study of older trauma patients found that those with a brain injury were 44% more likely to be diagnosed with Parkinson’s over the next five to seven years compared to people who experienced a similar-severity injury elsewhere on the body.
Early Warning Signs That Precede Movement Problems
Because the disease process begins years before the characteristic tremor and stiffness appear, there are subtle early signs that often go unrecognized. Loss of smell is one of the most common, present in nearly all patients by the time they’re diagnosed. It can appear 10 to 20 years before any movement symptoms. The olfactory bulb, the brain’s first processing station for smell, is one of the earliest areas where Lewy bodies accumulate.
Another telling early sign is REM sleep behavior disorder, a condition where people physically act out their dreams because the normal muscle paralysis during REM sleep is lost. This sleep disturbance shows up in almost half of people eventually diagnosed with Parkinson’s, and like smell loss, it can precede the motor symptoms by decades. Constipation, depression, and anxiety also appear frequently in the years before diagnosis.
Factors Linked to Lower Risk
Regular caffeine consumption, whether from coffee or tea, is consistently associated with a lower risk of Parkinson’s. A large meta-analysis found that people who regularly consumed caffeine had about a 20% lower risk of developing the disease. Caffeine blocks a specific receptor in the brain that, when activated, can make dopamine neurons more vulnerable to damage.
Physical activity also appears protective, though untangling cause from effect is tricky since people in the earliest undetected stages of Parkinson’s may naturally become less active. Still, the association holds across multiple large studies, and exercise has well-established benefits for mitochondrial health, inflammation, and the brain’s ability to adapt and repair.